2023
DOI: 10.1038/s41598-023-33443-1
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil

Abstract: The rapid spread of the SARS-CoV-2 Variant of Concern (VOC) Gamma in Amazonas during early 2021 fueled a second large COVID-19 epidemic wave and raised concern about the potential role of reinfections. Very few cases of reinfection associated with the VOC Gamma have been reported to date, and their potential impact on clinical, immunological, and virological parameters remains largely unexplored. Here we describe 25 cases of SARS-CoV-2 reinfection in Brazil. SARS-CoV-2 genomic analysis confirmed that individua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 66 publications
0
1
0
Order By: Relevance
“…PNAS 2023 ( He et al., 2023 )), we considered immune waning and immune escaping and our key conclusion holds. Finally, a very recent study of Gamma reinfections in different regions of Brazil makes clear “a low overall risk of severe Gamma reinfections, supporting that the abrupt increase in hospital admissions and deaths observed in Amazonas and other Brazilian states during the Gamma wave was mostly driven by primary infections” ( Naveca et al., 2023 ).…”
Section: Discussionmentioning
confidence: 94%
“…PNAS 2023 ( He et al., 2023 )), we considered immune waning and immune escaping and our key conclusion holds. Finally, a very recent study of Gamma reinfections in different regions of Brazil makes clear “a low overall risk of severe Gamma reinfections, supporting that the abrupt increase in hospital admissions and deaths observed in Amazonas and other Brazilian states during the Gamma wave was mostly driven by primary infections” ( Naveca et al., 2023 ).…”
Section: Discussionmentioning
confidence: 94%